Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

0.9800 +0.0007 (+0.07%)
Streaming Delayed Price Updated: 9:30 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2
Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephritis patients and raising $80 million to fund Phase 2. 
Via Benzinga
Tuesday's session: gap up and gap down stocks
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Adicet Bio (ACET) Q2 Loss Widens 3%
Via The Motley Fool
Adicet Bio: Q4 Earnings Insights
 
Via Benzinga
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
 
Via Benzinga
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news 
Via InvestorPlace
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023
ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
3 High-Risk Stocks That Could Pay Off in the Millions
With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time. 
Via InvestorPlace
Topics Stocks
7 Top-Tier Penny Stocks for a Smart Bet
Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers 
Via InvestorPlace
Topics Stocks
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these... 
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention. 
Via Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach
Why Are Gamma-Delta T Cells Important In Fighting Cancer? 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.